Karina Pogosian

Karina Pogosian


Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 August 2019 in Clinical and experimental thyroidology
Verified
Journal Article
Open access
LYLiubov G. Yanevskaya
Liubov G. Yanevskaya
TKTatiana Karonova
Tatiana Karonova
ISIlya Sleptsov
Ilya Sleptsov
MBMarina E. Boriskova
Marina E. Boriskova
ABAluza R. Bakhtiyarova
Aluza R. Bakhtiyarova
EGElena Grineva
Elena Grineva

1 April 2023 in Quantitative Imaging in Medicine and Surgery
Verified
Journal Article
Open access
PDF file
KPKarina Pogosian
Karina Pogosian
TKTatiana Karonova
Tatiana Karonova
DRDaria Ryzhkova
Daria Ryzhkova
LYLiubov Yanevskaya
Liubov Yanevskaya
UTUliana Tsoy
Uliana Tsoy
EGElena Grineva
Elena Grineva
Original Article 11C-methionine PET/CT and conventional imaging techniques in the diagnosis of primary hyperparathyroidism Karina Pogosian, Tatiana Karonova, Daria Ryzhkova, Liubov Yanevskaya, Uliana Tsoy, Olga Yudina, Gleb Berkovich, Anna Dalmatova, Elena Grineva

28 July 2023 in Russian Journal for Personalized Medicine
Verified
Journal Article
Open access
PDF file
KPKarina Pogosian
Karina Pogosian
TKT. L. Karonova
T. L. Karonova
DRD. V. Ryzhkova
D. V. Ryzhkova
UTU. A. Tsoy
U. A. Tsoy
ASA. N. Semenova
A. N. Semenova
EGE. N. Grineva
E. N. Grineva
Актуальность. Первичный гиперпаратиреоз (ПГПТ) — эндокринное заболевание, характеризующееся автономной секрецией паратиреоидного гормона (ПТГ). Радикальным методом лечения ПГПТ является паратиреоидэктомия (ПТЭ), результат которой в большой степени зависит от точной визуализации аденомы околощитовидных желез (ОЩЖ) на предоперационном этапе. К традиционным методам топической диагностики ПГПТ относятся ультразвуковое исследование (УЗИ), сцинтиграфия, мультиспиральная компьютерная томография (МСКТ), каждый из них имеет свои ограничения. С целью улучшения диагностики применяют позитронно-эмиссионную томографию/компьютерную томографию (ПЭТ/КТ) с 11C-метионином. Цель. Сравнить чувствительность и специфичность ПЭТ/КТ с 11С-метионином с аналогичными характеристиками традиционных методов визуализации аденом околощитовидных желез. Материалы и методы. Были проанализированы данные 91 больного с диагнозом ПГПТ. УЗИ, сцинтиграфия с 99mTc-сестамиби/99mTc-пертехнетатом и МСКТ были выполнены 91, 56 и 86 пациентам соответственно. С 2020 года ПЭТ/КТ с 11C-метионином использовалась в качестве завершающего метода топической диагностики у 45 больных. Оценка диагностических характеристик визуализирующих методов проводилась на основании результатов гистологического исследования. Результаты. Гистологическое исследование подтвердило наличие аденомы/гиперплазии ОЩЖ у всех больных. Множественные аденомы/гиперплазии были обнаружены в 5 случаях. Эктопированные аденомы были выявлены у 19 больных. Чувствительность ПЭТ/КТ с 11C-метионином составила 98 %, МСКТ, сцинтиграфии и УЗИ — 75 %, 79 %, 67 % соответственно. Специфичность — 93 %, 73 %, 75 %, 70 % соответственно. Заключение. ПЭТ/КТ с 11C-метионином продемонстрировала более высокие показатели чувствительности и специфичности, чем традиционные методы визуализации аденом ОЩЖ.

7 April 2021 in "Arterial’naya Gipertenziya" ("Arterial Hypertension")
Verified
Journal Article
Open access
PDF file
TKTatiana Karonova
Tatiana Karonova
KPKarina Pogosian
Karina Pogosian
LYLiubov G. Yanevskaya
Liubov G. Yanevskaya
OBOlga D. Belyaeva
Olga D. Belyaeva
EGElena Grineva
Elena Grineva
ЛЯЛ. Г. Яневская
Л. Г. Яневская
The review provides systematic information on the relation between pathology of parathyroid glands and cardiovascular disease (CVD). Recent studies have shown that actions of parathyroid hormone (PTH) and calcium affect the heart and vasculature through downstream actions of their receptors in the myocardium and endothelial cells, which lead to higher incidence of CVD among patients with parathyroid gland disorders (PGD). The mechanisms underlying this association also include insulin resistance and altered renin-angiotensinaldosterone axis among patients with primary hyperparathyroidism. However, low calcium and PTH level in hypoparathyroid patients are characterized by higher values of arterial stiffness, electrocardiogram abnormalities, vascular atherosclerosis and remodeling. These factors contribute to low quality of life among those patients. Knowledge of cardiovascular disease pathogenesis in patients with hyper- or hypoparathyroidism could help to improve quality of diagnostic and treatment and decrease the burden of cardiac risk factors. This review will be of interest to endocrinologists and cardiologists, and other specialists.

20 May 2023 in Translational Medicine
Verified
Journal Article
Open access
PDF file
KPKarina Pogosian
Karina Pogosian
TKTatiana Karonova
Tatiana Karonova
DRD. V. Ryzhkova
D. V. Ryzhkova
LYL. G. Yanevskaya
L. G. Yanevskaya
UTUliana A. Tsoy
Uliana A. Tsoy
EGElena Grineva
Elena Grineva
Background. Topical diagnosis of primary hyperparathyroidism (PHPT) remains an urgent problem due to the high incidence of persistence and recurrence after surgical treatment. At the preoperative stage, a search for the parathyroid hormone hyperproduction source is performed using instrumental methods: ultrasound, scintigraphy of the parathyroid glands (PTG) and multislice computed tomography (MSCT). The cause of PHPT persistence and recurrence after parathyroidectomy may be the multiple nature of PTG lesions or their ectopic location. Additional methods of visualization of PTG adenomas can be used to improve diagnosis (PET/CT).Objective. To compare the sensitivity and specificity of PET/CT with 11C-choline with the traditional visualization techniques.Design and methods. 16 PHPT patients were analyzed. All patients underwent US, subtraction scintigraphy with 99mTc-technetril/99mTc-pertechnitate and CT were performed in 12 and 16 patients, respectively. 11C-choline PET/CT was used for all patients. Imaging results’ coincidence of two methods were labeled as the true one.Results. The sensitivity of PET/CT with 11C-choline was 94 %, CT, subtraction scintigraphy with 99mTc-technetril/99mTc-pertechnitate and US — 75 %, 69 % and 63 %, respectively. The specificity of PET/CT with 11C-choline, CT, scintigraphy with 99mTc-technetril/99mTc-pertechnitate, and US was 100 %, 84 %, 76 %, and 68 %, respectively.Conclusion. PET/CT with 11C-choline demonstrated best sensitivity and specificity among all methods and can become an alternative in PHPT diagnostics in case of negative or inconvclusive results of previous visualization.

3 December 2024 in Diagnostics
Verified
Journal Article
Open access
PDF file
UTUliana A. Tsoy
Uliana A. Tsoy
KPKarina Pogosian
Karina Pogosian
DRDaria Ryzhkova
Daria Ryzhkova
OYOlga Yudina
Olga Yudina
KYKsenia Yakovenko
Ksenia Yakovenko
EGElena Grineva
Elena Grineva
Background: Parathyroid tumors are classified as parathyroid neuroendocrine neoplasia (NEN) by the IARC-WHO classification. These tumors can occur with NENs from other sites, which often require total-body [68Ga]-DOTA-peptides PET/CT. This study aimed to assess the utility of [68Ga]-DOTA-peptide PET/CT in imaging parathyroid NENs and to evaluate the underlying mechanisms. Methods: Fifty patients with primary hyperparathyroidism (PHPT) and parathyroid NENs histologically confirmed as parathyroid adenomas (PAs) were included. PET/CT with [68Ga]-DOTA-peptide was performed in 16 patients with localized PAs, including 10 with MEN1 syndrome. Somatostatin receptor types 2 and 5 (SST2 and SST5) staining was performed on PAs from 48 patients. Somatostatin analogs (SSA) were prescribed in four patients with MEN 1 syndrome and 1 with persistent acromegaly, all with PAs and PHPT. The therapy effects on calcium and parathyroid hormone (iPTH) were evaluated. Results: [68Ga]-DOTA-peptide PET/CT detected 20 PAs with high radiopharmaceutical uptake. SST2 expression was negative on PA cell membranes in all cases and positive on endothelium in 39 (81%) PAs. Membrane SST5 expression was positive in 25 (52%) PAs and endothelial was positive in 40 (83%). Serum calcium levels decreased in patients on SSA therapy, while iPTH did not. Conclusions: PET/CT with [68Ga]-DOTA-peptides can detect parathyroid NENs. The incidental detection of high [68Ga]-DOTA-peptide uptake in the parathyroid region during whole-body PET/CT may prompt biochemical evaluation for PHPT. We suggest that endothelial SST expression mediates high radiopharmaceutical uptake by PAs and that SSA treatment can reduce hypercalcemia in PHPT patients.